Your browser doesn't support javascript.
loading
A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers.
Xue, Xiangdong; Qu, Haijing; Bo, Ruonan; Zhang, Dalin; Zhu, Zheng; Xiang, Bai; Li, Longmeng; Ricci, Marina; Pan, Chong-Xian; Lin, Tzu-Yin; Li, Yuanpei.
Affiliation
  • Xue X; School of Pharmacy, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai, 200240, China; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA.
  • Qu H; School of Pharmacy, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai, 200240, China; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA.
  • Bo R; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA; School of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, China.
  • Zhang D; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA.
  • Zhu Z; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02132, USA.
  • Xiang B; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA; Key Laboratory of Hebei Province for Innovative Drug Research and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang
  • Li L; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA.
  • Ricci M; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA.
  • Pan CX; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02132, USA; VA Boston Healthcare System, Boston, MA, 02132, USA.
  • Lin TY; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA.
  • Li Y; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, 95817, USA. Electronic address: lypli@ucdavis.edu.
Biomaterials ; 299: 122145, 2023 08.
Article in En | MEDLINE | ID: mdl-37172536
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms Limits: Animals Language: En Journal: Biomaterials Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms Limits: Animals Language: En Journal: Biomaterials Year: 2023 Type: Article Affiliation country: United States